| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |